Novocure Ltd (NASDAQ:NVCR)

164.62
Delayed Data
As of Jan 26
 -2.64 / -1.58%
Today’s Change
53.40
Today|||52-Week Range
182.74
-4.87%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$17.2B

Company Description

NovoCure Ltd. develops treatment for tumors. Its platform is called the Tumor Treating Field which used electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.

Contact Information

Novocure Ltd.
No. 4 The Forum
St. Helier Jersey JE2 4UF
P:441534756700
Investor Relations:

Employees

Shareholders

Mutual fund holders48.57%
Individual stakeholders35.99%
Other institutional25.75%

Top Executives

Asaf DanzigerChief Executive Officer & Director
Wilco GroenhuysenChief Operating Officer
Ashley CordovaChief Financial Officer, SVP-Investor Relations
Uri WeinbergChief Science Officer
Ely BenaimChief Medical Officer